Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Payables (2016 - 2025)

Historic Payables for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $2.7 million.

  • iBio's Payables rose 11843.62% to $2.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.7 million, marking a year-over-year increase of 11843.62%. This contributed to the annual value of $3.0 million for FY2025, which is 41284.72% up from last year.
  • Latest data reveals that iBio reported Payables of $2.7 million as of Q4 2025, which was up 11843.62% from $3.5 million recorded in Q3 2025.
  • In the past 5 years, iBio's Payables registered a high of $27.0 million during Q3 2022, and its lowest value of $576000.0 during Q2 2024.
  • In the last 5 years, iBio's Payables had a median value of $3.2 million in 2025 and averaged $8.8 million.
  • As far as peak fluctuations go, iBio's Payables skyrocketed by 107835.95% in 2022, and later crashed by 9610.44% in 2024.
  • Over the past 5 years, iBio's Payables (Quarter) stood at $2.7 million in 2021, then soared by 630.67% to $20.0 million in 2022, then dropped by 27.48% to $14.5 million in 2023, then plummeted by 91.63% to $1.2 million in 2024, then soared by 118.44% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q4 2025, $3.5 million for Q3 2025, and $3.0 million during Q2 2025.